clinical trial
RedHill Biopharma's Opaganib Enters Phase II Trial With Nubeqa in Select Prostate Cancer Patients
Researchers will use a lipidomic biomarker test to select patients with a poor prognosis who may benefit from an investigational combination therapy.
The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.
Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.
ITM Eyes Regulatory Filing Following Positive Top-Line Readout in GEP-NETs
Patients on the firm's SSTR-targeted radiopharmaceutical had improved progression-free survival compared to patients on an mTor inhibitor in a Phase III trial.
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.